FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2527720274> ?p ?o ?g. }

• W2527720274 endingPage "785" @default.
• W2527720274 startingPage "779" @default.
• W2527720274 abstract "Pregabalin is approved by the US Food and Drug Administration for the treatment of fibromyalgia (FM), diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN), and neuropathic pain due to spinal cord injury (SCI). Approval was based on clinical trial data demonstrating statistically significant differences in pain scores versus placebo. However, statistically significant pain relief may not always equate to clinically meaningful pain relief. To further characterize the clinical benefit of pregabalin, this analysis examined shifts in pain severity categories in patients with FM, DPN/PHN (pooled in this analysis), and SCI treated with pregabalin.Data were pooled from 23 placebo-controlled trials in patients with FM (1,623 treated with pregabalin, 937 placebo), DPN/PHN (2,867 pregabalin, 1,532 placebo), or SCI (181 pregabalin, 175 placebo). Pain scores were assessed on an 11-point numeric rating scale and categorized as mild (0 to <4), moderate (4 to <7), or severe (7 to 10). Only patients with mean score ≥4 at baseline were randomized to treatment. The percentage of patients shifting pain category from baseline to endpoint for pregabalin and placebo was analyzed using a modified ridit transformation with the Cochran-Mantel-Haenszel procedure.A higher proportion of patients shifted to a less severe pain category at endpoint with pregabalin compared with placebo. With flexible-dose pregabalin, the percentage of patients improving from: severe to mild (pregabalin versus placebo) was 15.8 versus 13.4 in FM patients, 36.0 versus 16.6 in DPN/PHN patients, 14.3 versus 7.7 in SCI patients; severe to moderate was 28.7 versus 28.2 in FM patients, 32.5 versus 28.2 in DPN/PHN patients, 35.7 versus 28.2 in SCI patients; and moderate to mild was 38.3 versus 26.4 in FM patients, 59.5 versus 41.4 in DPN/PHN patients, 38.6 versus 27.2 in SCI patients.Compared with placebo, pregabalin is more often associated with clinically meaningful improvements in pain category in patients with FM, DPN, PHN, or SCI." @default.
• W2527720274 created "2016-10-14" @default.
• W2527720274 creator A5020043337 @default.
• W2527720274 creator A5025969986 @default.
• W2527720274 creator A5031987528 @default.
• W2527720274 creator A5042073172 @default.
• W2527720274 date "2016-10-01" @default.
• W2527720274 modified "2023-09-26" @default.
• W2527720274 title "Improvement in pain severity category in clinical trials of pregabalin" @default.
• W2527720274 cites W1845521331 @default.
• W2527720274 cites W1935029288 @default.
• W2527720274 cites W1963982330 @default.
• W2527720274 cites W1972387365 @default.
• W2527720274 cites W1980324994 @default.
• W2527720274 cites W1988364618 @default.
• W2527720274 cites W1992436256 @default.
• W2527720274 cites W2001638015 @default.
• W2527720274 cites W2002718846 @default.
• W2527720274 cites W2011913908 @default.
• W2527720274 cites W2020407769 @default.
• W2527720274 cites W2038826804 @default.
• W2527720274 cites W2053495101 @default.
• W2527720274 cites W2054260401 @default.
• W2527720274 cites W2063925605 @default.
• W2527720274 cites W2068602147 @default.
• W2527720274 cites W2068757724 @default.
• W2527720274 cites W2070246197 @default.
• W2527720274 cites W2070651571 @default.
• W2527720274 cites W2076370391 @default.
• W2527720274 cites W2076716839 @default.
• W2527720274 cites W2080255943 @default.
• W2527720274 cites W2091238378 @default.
• W2527720274 cites W2094822188 @default.
• W2527720274 cites W2120306614 @default.
• W2527720274 cites W2128412489 @default.
• W2527720274 cites W2132880177 @default.
• W2527720274 cites W2148029309 @default.
• W2527720274 cites W2150703501 @default.
• W2527720274 cites W2152802140 @default.
• W2527720274 cites W2158523533 @default.
• W2527720274 cites W2159977024 @default.
• W2527720274 cites W2161344815 @default.
• W2527720274 cites W2162351636 @default.
• W2527720274 cites W2164632241 @default.
• W2527720274 cites W2253364553 @default.
• W2527720274 cites W2280631568 @default.
• W2527720274 cites W2346744058 @default.
• W2527720274 doi "https://doi.org/10.2147/jpr.s102696" @default.
• W2527720274 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5063480" @default.
• W2527720274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27785092" @default.
• W2527720274 hasPublicationYear "2016" @default.
• W2527720274 type Work @default.
• W2527720274 sameAs 2527720274 @default.
• W2527720274 citedByCount "10" @default.
• W2527720274 countsByYear W25277202742017 @default.
• W2527720274 countsByYear W25277202742018 @default.
• W2527720274 countsByYear W25277202742019 @default.
• W2527720274 countsByYear W25277202742021 @default.
• W2527720274 countsByYear W25277202742022 @default.
• W2527720274 crossrefType "journal-article" @default.
• W2527720274 hasAuthorship W2527720274A5020043337 @default.
• W2527720274 hasAuthorship W2527720274A5025969986 @default.
• W2527720274 hasAuthorship W2527720274A5031987528 @default.
• W2527720274 hasAuthorship W2527720274A5042073172 @default.
• W2527720274 hasBestOaLocation W25277202741 @default.
• W2527720274 hasConcept C126322002 @default.
• W2527720274 hasConcept C142724271 @default.
• W2527720274 hasConcept C1862650 @default.
• W2527720274 hasConcept C203092338 @default.
• W2527720274 hasConcept C204787440 @default.
• W2527720274 hasConcept C27081682 @default.
• W2527720274 hasConcept C2776468701 @default.
• W2527720274 hasConcept C2777107010 @default.
• W2527720274 hasConcept C2777831278 @default.
• W2527720274 hasConcept C2778866549 @default.
• W2527720274 hasConcept C2780052408 @default.
• W2527720274 hasConcept C2781118164 @default.
• W2527720274 hasConcept C42219234 @default.
• W2527720274 hasConcept C535046627 @default.
• W2527720274 hasConcept C71924100 @default.
• W2527720274 hasConceptScore W2527720274C126322002 @default.
• W2527720274 hasConceptScore W2527720274C142724271 @default.
• W2527720274 hasConceptScore W2527720274C1862650 @default.
• W2527720274 hasConceptScore W2527720274C203092338 @default.
• W2527720274 hasConceptScore W2527720274C204787440 @default.
• W2527720274 hasConceptScore W2527720274C27081682 @default.
• W2527720274 hasConceptScore W2527720274C2776468701 @default.
• W2527720274 hasConceptScore W2527720274C2777107010 @default.
• W2527720274 hasConceptScore W2527720274C2777831278 @default.
• W2527720274 hasConceptScore W2527720274C2778866549 @default.
• W2527720274 hasConceptScore W2527720274C2780052408 @default.
• W2527720274 hasConceptScore W2527720274C2781118164 @default.
• W2527720274 hasConceptScore W2527720274C42219234 @default.
• W2527720274 hasConceptScore W2527720274C535046627 @default.
• W2527720274 hasConceptScore W2527720274C71924100 @default.
• W2527720274 hasLocation W25277202741 @default.
• W2527720274 hasLocation W25277202742 @default.
• W2527720274 hasLocation W25277202743 @default.

• next